A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer have?
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer has 7 citations in the OpenAlex counts ScholarIQ stores.
When was A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer published?
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer has 2023 year in the ScholarIQ index.
What is the open-access status of A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer?
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer has gold oa status in the ScholarIQ index.
What is the DOI of A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer?
The DOI for A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer is on the source record.
What is the PMID of A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer?
The PMID for A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer is on the source record.
What is the OpenAlex record for A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer?
The OpenAlex for A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer is on the source record.